{'fraction_non_alphanumeric': 0.03220338983050847, 'fraction_numerical': 0.020338983050847456, 'mean_word_length': 6.3875, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Anaemia in HIV‐infected pregnant women receiving triple antiretroviral combination therapy for prevention of mother‐to‐child transmission: a secondary analysis of the Kisumu breastfeeding study (KiBS)

The prevalence of anaemia during pregnancy is estimated to be 35–75% in sub‐Saharan Africa and is associated with an increased risk of maternal mortality. We evaluated the frequency and factors associated with anaemia in HIV‐infected women undergoing antiretroviral (ARV) therapy for prevention of mother‐to‐child transmission (PMTCT) enrolled in The Kisumu Breastfeeding Study 2003–2009.